Participants 77 172 7
hyperglycemia in patients with type 2 diabetes inadequately controlled by metformin monotherapy
Participants 471 552 5
patients with type 2 diabetes exhibiting inadequate glycemic control (A1C 7-11%).
Participants 581 811 7
This double-blind placebo-controlled paralleled study randomized 302 patients with type 2 diabetes (mean A1C 8.3%) on metformin monotherapy (mean 1.5 g/day) to receive one of five INCB13739 doses or placebo once daily for 12 weeks
Participants 1767 1853 4
patients with type 2 diabetes who had inadequate glycemic control with metformin alone
Participants 1963 1978 3
type 2 diabetes
